Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
500.49
+4.66 (0.94%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$511.27
Upside
+2.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $408 → $420 | Hold | Maintains | $408 → $420 | -16.08% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $555 → $567 | Strong Buy | Maintains | $555 → $567 | +13.29% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $407 → $408 | Hold | Maintains | $407 → $408 | -18.48% | Feb 20, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell → Hold Upgrades $408 → $424 | Strong Sell → Hold | Upgrades | $408 → $424 | -15.28% | Feb 12, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $460 → $520 | Strong Buy | Maintains | $460 → $520 | +3.90% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $402 → $407 | Hold | Maintains | $402 → $407 | -18.68% | Feb 11, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $433 → $450 | Hold | Maintains | $433 → $450 | -10.09% | Feb 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | -4.09% | Feb 11, 2025 |
| Barclays | Barclays | Hold Maintains $435 → $467 | Hold | Maintains | $435 → $467 | -6.69% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $550 | Strong Buy | Reiterates | $550 | +9.89% | Feb 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $450 → $459 | Hold | Maintains | $450 → $459 | -8.29% | Feb 11, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | -4.09% | Jan 31, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $430 → $433 | Hold | Maintains | $430 → $433 | -13.48% | Jan 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $535 → $550 | Strong Buy | Maintains | $535 → $550 | +9.89% | Jan 31, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 31, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.